Delta-Fly Pharma: Short statement of financial results for Q1 in March 2025 (based on Japanese standards, non-consolidated).

JPX · Aug 9 14:05

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.